Showing results (81-90 of 166) with videos related to
Sort By:
Pageof 17
Investigational New Drugs|January 1, 1985
A phase II study of spirogermanium as second line therapy in patients with poor prognosis lymphoma. An NCI Canada Clinical Trials Group StudyE Eisenhauer, I Quirt, J M Connors, et al.Pediatric Emergency Care|March 27, 2001
Delayed diagnosis in pediatric blunt traumaJ M Connors, R M Ruddy, J McCall, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2004
Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classificationK J Savage, M Chhanabhai, R D Gascoyne, et al.Hematological Oncology|March 22, 2000
Anaplastic large cell lymphoma: a clinicopathologic analysisB F Skinnider, J M Connors, S B Sutcliffe, et al.American Journal of Clinical Pathology|June 1, 1985
Diffuse malignant lymphoma with cerebriform nuclei: A B-cell lymphoma studied with monoclonal antibodiesJ S Burke, R A Warnke, J M Connors, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1988
Testicular lymphoma: improved outcome with early brief chemotherapyJ M Connors, P Klimo, N Voss, et al.Clinics in Geriatric Medicine|May 1, 1997
Malignant lymphomas in the elderlyS E O'Reilly, J M Connors, N Macpherson, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 12, 2012
Patients' and physicians' roles in detecting recurrent Hodgkin lymphoma following complete remissionA Bestawros, L Foltz, N Srour, et al.Bone Marrow Transplantation|July 1, 1990
Intensive chemotherapy and autologous peripheral blood stem cell transplantation in a patient with persistent marrow involvement with Hodgkin's diseaseG L Phillips, D E Reece, K G Lerner, et al.Blood|October 24, 1997
Prognostic significance of Bax protein expression in diffuse aggressive non-Hodgkin's lymphomaR D Gascoyne, M Krajewska, S Krajewski, et al.Pageof 17